Trial intelligence / Profile preview

Influence of Smoking on Prasugrel vs Clopidogrel PK/PD in Stable CAD

NCT01260584Phase 4Completed

Sponsor
Daiichi Sankyo Co., Ltd.
Start
Nov 2010
Primary completion
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of prasugrel in coronary artery disease (CAD), sponsored by Daiichi Sankyo Co., Ltd.. Started Nov 2010; status: completed.

02

Drugs

prasugrel
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01260584.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01260584.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call